Axsome Therapeutics to Participate in Four Investor Conferences
Bitget2026/11/03 12:05- Axsome Therapeutics to join Guggenheim’s 3rd Annual Healthcare Innovation Conference in Boston Nov. 9, 2026; fireside chat at 11:30 a.m. ET.
- Investor meetings at the 8th Annual Wolfe Research Healthcare Conference in New York scheduled for Nov. 10, 2026.
- Participation in the 2026 Truist BioPharma Symposium includes investor meetings Nov. 12, 2026, in New York.
- A fireside chat at UBS Global Biopharma Conference 2026 in London is scheduled for Nov. 16 at 11:20 a.m. GMT.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SoftBank develops contingency plans for slowdown in US data center business, considers shifting to other countries
A new twist has emerged in the US AI data center investment boom. SoftBank is preparing for cooling US demand and a deteriorating political environment, and does not rule out shifting data center construction priorities to other countries. As cross-border computing power delivery capability improves and investment returns come under question, the logic behind AI infrastructure expansion is loosening, and over $3.5 trillion in infrastructure investment now faces potential impairment risks.
Quantumrail Cancels 10 Billion Won Convertible Bond Offering
Crypto prices
More
